HC
ITCI

Henshaw Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Henshaw Capital’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,336
Closed -$279K – 306
2024
Q4 		$279K Hold
3,336
– – 0.01% 281
2024
Q3 		$244K Sell
3,336
-5,064
-60% -$381K 0.01% 296
2024
Q2 		$575K Buy
8,400
+156
+2% +$10.8K 0.03% 160
2024
Q1 		$570K Sell
8,244
-1,026
-11% -$70.5K 0.03% 155
2023
Q4 		$664K Buy
9,270
+1,529
+20% +$88K 0.03% 139
2023
Q3 		$403K Buy
+7,741
New +$451K 0.02% 179

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.37B AUM 63.08% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return